These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20536425)

  • 1. CCR1 antagonists: what have we learned from clinical trials.
    Gladue RP; Brown MF; Zwillich SH
    Curr Top Med Chem; 2010; 10(13):1268-77. PubMed ID: 20536425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human specific CCR1 antagonist CP-481,715 inhibits cell infiltration and inflammatory responses in human CCR1 transgenic mice.
    Gladue RP; Cole SH; Roach ML; Tylaska LA; Nelson RT; Shepard RM; McNeish JD; Ogborne KT; Neote KS
    J Immunol; 2006 Mar; 176(5):3141-8. PubMed ID: 16493073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCR1 chemokine receptor antagonist.
    Saeki T; Naya A
    Curr Pharm Des; 2003; 9(15):1201-8. PubMed ID: 12769747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D-pharmacophere models for CC chemokine receptor 1 antagonists.
    Liu Y; Andre P; Wei J; Zhao K
    Med Chem; 2009 Jul; 5(4):318-24. PubMed ID: 19689388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CP-481,715, a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseases.
    Gladue RP; Tylaska LA; Brissette WH; Lira PD; Kath JC; Poss CS; Brown MF; Paradis TJ; Conklyn MJ; Ogborne KT; McGlynn MA; Lillie BM; DiRico AP; Mairs EN; McElroy EB; Martin WH; Stock IA; Shepard RM; Showell HJ; Neote K
    J Biol Chem; 2003 Oct; 278(42):40473-80. PubMed ID: 12909630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR1 antagonists for the treatment of autoimmune diseases.
    Gladue RP; Zwillich SH; Clucas AT; Brown MF
    Curr Opin Investig Drugs; 2004 May; 5(5):499-504. PubMed ID: 15202722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel pyrrolidine ureas as C-C chemokine receptor 1 (CCR1) antagonists.
    Merritt JR; Liu J; Quadros E; Morris ML; Liu R; Zhang R; Jacob B; Postelnek J; Hicks CM; Chen W; Kimble EF; Rogers WL; O'Brien L; White N; Desai H; Bansal S; King G; Ohlmeyer MJ; Appell KC; Webb ML
    J Med Chem; 2009 Mar; 52(5):1295-301. PubMed ID: 19183043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MLN3897 plus methotrexate in patients with rheumatoid arthritis: safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study.
    Vergunst CE; Gerlag DM; von Moltke L; Karol M; Wyant T; Chi X; Matzkin E; Leach T; Tak PP
    Arthritis Rheum; 2009 Dec; 60(12):3572-81. PubMed ID: 19950299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of CCR1 antagonists for multiple myeloma.
    Karash AR; Gilchrist A
    Future Med Chem; 2011 Nov; 3(15):1889-908. PubMed ID: 22023033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying bias in CCR1 antagonists using radiolabelled binding, receptor internalization, β-arrestin translocation and chemotaxis assays.
    Gilchrist A; Gauntner TD; Fazzini A; Alley KM; Pyen DS; Ahn J; Ha SJ; Willett A; Sansom SE; Yarfi JL; Bachovchin KA; Mazzoni MR; Merritt JR
    Br J Pharmacol; 2014 Nov; 171(22):5127-38. PubMed ID: 24990525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR1 antagonists.
    Cheng JF; Jack R
    Mol Divers; 2008 Feb; 12(1):17-23. PubMed ID: 18560988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome.
    Vielhauer V; Berning E; Eis V; Kretzler M; Segerer S; Strutz F; Horuk R; Gröne HJ; Schlöndorff D; Anders HJ
    Kidney Int; 2004 Dec; 66(6):2264-78. PubMed ID: 15569315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of the CCR1 antagonist, BMS-817399, for the treatment of rheumatoid arthritis.
    Santella JB; Gardner DS; Duncia JV; Wu H; Dhar M; Cavallaro C; Tebben AJ; Carter PH; Barrish JC; Yarde M; Briceno SW; Cvijic ME; Grafstrom RR; Liu R; Patel SR; Watson AJ; Yang G; Rose AV; Vickery RD; Caceres-Cortes J; Caporuscio C; Camac DM; Khan JA; An Y; Foster WR; Davies P; Hynes J
    J Med Chem; 2014 Sep; 57(18):7550-64. PubMed ID: 25101488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AZD-4818, a chemokine CCR1 antagonist: WO2008103126 and WO2009011653.
    Norman P
    Expert Opin Ther Pat; 2009 Nov; 19(11):1629-33. PubMed ID: 19586423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel non-peptide CCR1 receptor antagonists.
    Ng HP; May K; Bauman JG; Ghannam A; Islam I; Liang M; Horuk R; Hesselgesser J; Snider RM; Perez HD; Morrissey MM
    J Med Chem; 1999 Nov; 42(22):4680-94. PubMed ID: 10579830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR1 and CCR2 antagonists.
    Zimmermann HW; Sterzer V; Sahin H
    Curr Top Med Chem; 2014; 14(13):1539-52. PubMed ID: 25159163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR2 antagonists.
    Struthers M; Pasternak A
    Curr Top Med Chem; 2010; 10(13):1278-98. PubMed ID: 20536421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CC chemokine receptor small molecule antagonists in the treatment of rheumatoid arthritis and other diseases: a current view.
    Liu J; Merritt JR
    Curr Top Med Chem; 2010; 10(13):1250-67. PubMed ID: 20536422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-aryl pyrazoles, indazoles and azaindazoles as antagonists of CC chemokine receptor 1: patent cooperation treaty applications WO2010/036632, WO2009/134666 and WO2009/137338.
    Carter PH; Hynes J
    Expert Opin Ther Pat; 2010 Nov; 20(11):1609-18. PubMed ID: 20858032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological intervention at CCR1 and CCR5 as an approach for cancer: help or hindrance.
    Karash A; Mazzoni MR; Gilchrist A
    Curr Top Med Chem; 2014; 14(13):1553-73. PubMed ID: 25159162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.